The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Fallopian tube precursors of ovarian low‐ and high‐grade serous neoplasms
Abstract
Traditionally, it was thought that ovarian high‐grade serous carcinoma arises from the ovarian surface epithelium and epithelial inclusion glands and that the pathogenesis is de novo; nonetheless, a convincing precursor in the ovary or peritoneum has not been identified to date. During the last few years, however, there has been a dramatic shift in thinking, and a candidate precursor is now recognized in the fallopian tube, especially within the fimbriated end – serous tubal intra‐epithelial carcinoma (STIC). Accordingly, STIC is probably the earliest histologically recognizable lesion in the pathogenesis of high‐grade serous carcinoma, but steps in this pathway which precede STIC have also been proposed. With subsequent progression, STIC implants onto the ovary and then develops into an invasive high‐grade serous carcinoma with rapid tumour growth. For invasive low‐grade serous carcinoma, it is well‐established that its pathogenesis begins with serous cystadenoma/adenofibroma, which develops sequentially into atypical proliferative serous tumour (typical serous borderline tumour), non‐invasive micropapillary (low‐grade) serous carcinoma (micropapillary serous borderline tumour) and then invasive low‐grade serous carcinoma in a relatively slow stepwise process. It is presumed that cystadenoma/adenofibroma arises from epithelial inclusion glands in the ovary, but recent evidence suggests that epithelial inclusion glands originate in the fallopian tube. Alternatively, it has been proposed that the other early precursors in the low‐grade pathway, including serous borderline tumours, non‐invasive implants and endosalpingiosis, may also arise directly from tubal mucosa. Therefore, the precursor of most ovarian high‐grade serous carcinomas originates in the fallopian tube, and that for low‐grade serous tumours may also be derived from the tube. This review paper provides an overview of the fallopian tube's potential role in the pathogenesis of both types of serous neoplasms of the ovary.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory
Kurman, R. J., & Shih, I.-M. (2010) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3181cf3d79 · Cited by 1,846
Self-citationINCESSANT OVULATION—A FACTOR IN OVARIAN NEOPLASIA ?
Fathalla, M. F. (1971) · The Lancet · doi:10.1016/s0140-6736(71)92335-x · Cited by 1,119
Kindelberger, D. W., Lee, Y., Miron, A., Hirsch, M. S., Feltmate, C., Medeiros, F., Callahan, M. J., Garner, E. O., Gordon, R. W., Birch, C., et al. (2007) · The American Journal of Surgical Pathology · doi:10.1097/01.pas.0000213335.40358.47 · Cited by 1,113
Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer—Shifting the paradigm
Kurman, R. J., & Shih, I.-M. (2011) · Human Pathology · doi:10.1016/j.humpath.2011.03.003 · Cited by 1,073
Self-citationMedeiros, F., Muto, M. G., Lee, Y., Elvin, J. A., Callahan, M. J., Feltmate, C., Garber, J. E., Cramer, D. W., & Crum, C. P. (2006) · American Journal of Surgical Pathology · doi:10.1097/01.pas.0000180854.28831.77 · Cited by 916
A candidate precursor to serous carcinoma that originates in the distal fallopian tube
Lee, Y., Miron, A., Drapkin, R., Nucci, M., Medeiros, F., Saleemuddin, A., Garber, J., Birch, C., Mou, H., Gordon, R., et al. (2007) · The Journal of Pathology · doi:10.1002/path.2091 · Cited by 898
Vang, R., Shih, I.-M., & Kurman, R. J. (2009) · Advances in Anatomic Pathology · doi:10.1097/pap.0b013e3181b4fffa · Cited by 562
Self-citationYemelyanova, A., Vang, R., Kshirsagar, M., Lu, D., Marks, M. A., Shih, I. M., & Kurman, R. J. (2011) · Modern Pathology · doi:10.1038/modpathol.2011.85 · Cited by 513
Self-citationCallahan, M. J., Crum, C. P., Medeiros, F., Kindelberger, D. W., Elvin, J. A., Garber, J. E., Feltmate, C. M., Berkowitz, R. S., & Muto, M. G. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.2622 · Cited by 485
Are All Pelvic (Nonuterine) Serous Carcinomas of Tubal Origin?
Przybycin, C. G., Kurman, R. J., Ronnett, B. M., Shih, I.-M., & Vang, R. (2010) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3181ef7b16 · Cited by 410
Self-citationOrigins and molecular pathology of ovarian cancer
Bell, D. A. (2005) · Modern Pathology · doi:10.1016/s0893-3952(22)04456-8 · Cited by 387
Kuhn, E., Kurman, R. J., Vang, R., Sehdev, A. S., Han, G., Soslow, R., Wang, T., & Shih, I. (2012) · The Journal of Pathology · doi:10.1002/path.3023 · Cited by 387
Self-citationPrecursor lesions of ovarian epithelial malignancy
Feeley, K. M., & Wells, M. (2001) · Histopathology · doi:10.1046/j.1365-2559.2001.01042.x · Cited by 351
Carlson, J. W., Miron, A., Jarboe, E. A., Parast, M. M., Hirsch, M. S., Lee, Y., Muto, M. G., Kindelberger, D., & Crum, C. P. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.4814 · Cited by 347
Colgan, T. J., Murphy, J., Cole, D. E. C., Narod, S., & Rosen, B. (2001) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200110000-00009 · Cited by 327
Epidemiology of Ovarian Cancer
Permuth-Wey, J., & Sellers, T. A. (2009) · Methods in Molecular Biology · doi:10.1007/978-1-60327-492-0_20 · Cited by 326
Longacre, T. A., McKenney, J. K., Tazelaar, H. D., Kempson, R. L., & Hendrickson, M. R. (2005) · American Journal of Surgical Pathology · doi:10.1097/01.pas.0000164030.82810.db · Cited by 323
Marquez, R. T., Baggerly, K. A., Patterson, A. P., Liu, J., Broaddus, R., Frumovitz, M., Atkinson, E. N., Smith, D. I., Hartmann, L., Fishman, D., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2509 · Cited by 308
Folkins, A. K., Jarboe, E. A., Saleemuddin, A., Lee, Y., Callahan, M. J., Drapkin, R., Garber, J. E., Muto, M. G., Tworoger, S., & Crum, C. P. (2008) · Gynecologic Oncology · doi:10.1016/j.ygyno.2008.01.012 · Cited by 293
Serous Carcinogenesis in the Fallopian Tube: A Descriptive Classification
Jarboe, E., Folkins, A., Nucci, M. R., Kindelberger, D., Drapkin, R., Miron, A., Lee, Y., & Crum, C. P. (2008) · International Journal of Gynecological Pathology · doi:10.1097/pgp.0b013e31814b191f · Cited by 273
Pathology of ovarian cancer precursors
Scully, R. E. (1995) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240590928 · Cited by 264
Identification of Molecular Pathway Aberrations in Uterine Serous Carcinoma by Genome-wide Analyses
Kuhn, E., Wu, R.-C., Guan, B., Wu, G., Zhang, J., Wang, Y., Song, L., Yuan, X., Wei, L., Roden, R. B. S., et al. (2012) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djs345 · Cited by 247
Self-citationVisvanathan, K., Vang, R., Shaw, P., Gross, A., Soslow, R., Parkash, V., Shih, I.-M., & Kurman, R. J. (2011) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e31822f58bc · Cited by 177
Self-citationSerous Borderline Tumors of the Peritoneum
Bell, D. A., & Scully, R. E. (1990) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199003000-00004 · Cited by 168
Dehari, R., Kurman, R. J., Logani, S., & Shih, I. (2007) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e31802cbbe9 · Cited by 168
Self-citationSecretory cell outgrowth, PAX2 and serous carcinogenesis in the Fallopian tube
Chen, E. Y., Mehra, K., Mehrad, M., Ning, G., Miron, A., Mutter, G. L., Monte, N., Quade, B. J., McKeon, F. D., Yassin, Y., et al. (2010) · The Journal of Pathology · doi:10.1002/path.2739 · Cited by 161
Validation of an Algorithm for the Diagnosis of Serous Tubal Intraepithelial Carcinoma
Vang, R., Visvanathan, K., Gross, A., Maambo, E., Gupta, M., Kuhn, E., Li, R. F., Ronnett, B. M., Seidman, J. D., Yemelyanova, A., et al. (2012) · International Journal of Gynecological Pathology · doi:10.1097/pgp.0b013e31823b8831 · Cited by 159
Self-citationTubal origin of ‘ovarian’ low-grade serous carcinoma
Li, J., Shahin, N. A., Pang, S., Li, X., Chambers, S. K., Fadare, O., Kong, B., & Zheng, W. (2011) · Modern Pathology · doi:10.1038/modpathol.2011.106 · Cited by 156
Kuhn, E., Meeker, A. K., Wang, T., Sehdev, A. E. S., Kurman, R. J., & Shih, I. (2010) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3181dcede7 · Cited by 154
Self-citationTone, A. A., Begley, H., Sharma, M., Murphy, J., Rosen, B. P., Brown, T. J., & Shaw, P. A. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4959 · Cited by 153
Kurman, R. J., VANG, R. S., Junge, J., Hannibal, C. G., Kjær, S. K., & Shih, I. (2011) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e318229449f · Cited by 150
Self-citationEVENTS OF REPRODUCTIVE LIFE AND THE INCIDENCE OF EPITHELIAL OVARIAN CANCER
Risch, H. A., Weiss, N. S., Lyon, J. L., Daling, J. R., & Liff, J. M. (1983) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a113523 · Cited by 143
The Origin of Ovarian Carcinomas: A Unifying Hypothesis
Auersperg, N. (2010) · International Journal of Gynecological Pathology · doi:10.1097/pgp.0b013e3181f45f3e · Cited by 133
Serous Tubal Intraepithelial Carcinoma and the Dominant Ovarian Mass: Clues to Serous Tumor Origin?
Roh, M. H., Kindelberger, D. W., & Crum, C. P. (2009) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3181868904 · Cited by 133
Carcangiu, M. L., Peissel, B., Pasini, B., Spatti, G., Radice, P., & Manoukian, S. (2006) · The American Journal of Surgical Pathology · doi:10.1097/01.pas.0000202161.80739.ac · Cited by 131
Salvador, S. C., Rempel, A., Soslow, R. A., Gilks, C. B., Huntsman, D. D., & Miller, D. M. (2008) · Gynecologic Oncology · doi:10.1016/j.ygyno.2008.05.010 · Cited by 117
Disabled-2 inactivation is an early step in ovarian tumorigenicity
Fazili, Z., Sun, W., Mittelstaedt, S., Cohen, C., & Xu, X.-X. (1999) · Oncogene · doi:10.1038/sj.onc.1202649 · Cited by 116
STICS SCOUTs and p53 signatures a new language for pelvic serous carcinogenesis
Crum, C. P. (2010) · Frontiers in Bioscience-Elite · doi:10.2741/e275 · Cited by 111
Predictors of occult neoplasia in women undergoing risk-reducing salpingo-oophorectomy.
Lamb, J., Garcia, R., Goff, B., Paley, P., & Swisher, E. (2006) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2006.03.006 · Cited by 105
The post-reproductive Fallopian tube: better removed?
Dietl, J., Wischhusen, J., & Häusler, S. F. (2011) · Human Reproduction · doi:10.1093/humrep/der274 · Cited by 100
Gu, J., Roth, L. M., Younger, C., Michael, H., Abdul‐Karim, F. W., Zhang, S., Ulbright, T. M., Eble, J. N., & Cheng, L. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.15.1147 · Cited by 94
McCluggage, W. G., Soslow, R. A., & Gilks, C. B. (2011) · Histopathology · doi:10.1111/j.1365-2559.2011.03907.x · Cited by 93
Boyd, C., & McCluggage, W. G. (2011) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e31823732a9 · Cited by 88
Evidence for the multifocal origin of bilateral and advanced human serous borderline ovarian tumors.
Lu, K. H., Bell, D. A., Welch, W. R., Berkowitz, R. S., & Mok, S. C. (1998) · PubMed · Cited by 79
Shvartsman, H. S., Sun, C. C., Bodurka, D. C., Mahajan, V., Crispens, M. A., Lu, K. H., Deavers, M. T., Malpica, A. L., Silva, E. G., & Gershenson, D. M. (2007) · Gynecologic Oncology · doi:10.1016/j.ygyno.2007.01.030 · Cited by 73
Roland, I. H., Yang, W., Yang, D., Daly, M. B., Ozols, R. F., Hamilton, T. C., Lynch, H. T., Godwin, A. K., & Xu, X. (2003) · Cancer · doi:10.1002/cncr.11847 · Cited by 70
Yang, D., Smith, E. R., Cohen, C., Wu, H., Patriotis, C., Godwin, A. K., Hamilton, T. C., & Xu, X. (2002) · Cancer · doi:10.1002/cncr.10497 · Cited by 67
Endosalpingiosis of the peritoneum.
Burmeister, R. E., Re, F., & Rr, F. (1969) · PubMed · Cited by 57
Early Recurrence of Ovarian Serous Borderline Tumor as High-grade Carcinoma: A Report of Two Cases
Parker, R. L., Clement, P. B., Chercover, D. J., Sornarajah, T., & Gilks, C. B. (2004) · International Journal of Gynecological Pathology · doi:10.1097/01.pgp.0000130049.19643.f6 · Cited by 57
Kuhn, E., Kurman, R. J., Soslow, R. A., Han, G., Sehdev, A. E. S., Morin, P., Wang, T., & Shih, I. (2012) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e31825ec07a · Cited by 57
Self-citationMehra, K. K., Chang, M. C., Folkins, A. K., Raho, C. J., Lima, J. F., Yuan, L., Mehrad, M., Tworoger, S. S., Crum, C. P., & Saleemuddin, A. (2010) · Modern Pathology · doi:10.1038/modpathol.2010.171 · Cited by 46
K-RAS Mutations in Ovarian and Extraovarian Lesions of Serous Tumors of Borderline Malignancy
Diebold, J., Seemüller, F., & Löhrs, U. (2003) · Laboratory Investigation · doi:10.1097/01.lab.0000056994.81259.32 · Cited by 44
Garg, K., Park, K. J., & Soslow, R. A. (2012) · International Journal of Gynecological Pathology · doi:10.1097/pgp.0b013e31824ae6f2 · Cited by 43
K-ras Mutations in Müllerian Inclusion Cysts Associated with Serous Borderline Tumors of the Ovary
Secord, A. A., MOORE, W. F., Robboy, S. J., Bentley, R. C., Gumbs, C. E., Futreal, P. A., & Berchuck, A. (2001) · Gynecologic Oncology · doi:10.1006/gyno.2000.6066 · Cited by 41
Agoff, S. N., Garcia, R. L., Goff, B. A., & Swisher, E. M. (2004) · The American Journal of Surgical Pathology · doi:10.1097/01.pas.0000131554.05732.cd · Cited by 36
Diseases of the Fallopian Tube and Paratubal Region
VANG, R. S., & Wheeler, J. E. (2010) · Springer eBooks · doi:10.1007/978-1-4419-0489-8_11 · Cited by 29
Self-citationZanotti, K. M., Hart, W. R., KENNEDY, A. W., Belinson, J. L., & Casey, G. (1999) · International Journal of Gynecological Pathology · doi:10.1097/00004347-199907000-00010 · Cited by 14
Cited by
Epidemiology of ovarian cancer: a review
Brett M., R., Brett M., R., Jennifer B., P., Thomas A., S., Jennifer B., P., & Thomas A., S. (2017) · Cancer Biology & Medicine · doi:10.20892/j.issn.2095-3941.2016.0084 · Cited by 1,524
Ledermann, J. A., Raja, F. A., Fotopoulou, C., Gonzalez-Martin, A., Colombo, N., & Sessa, C. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt333 · Cited by 1,104
Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer
Phelan, C. M., Kuchenbaecker, K. B., Tyrer, J. P., Kar, S. P., Lawrenson, K., Winham, S. J., Dennis, J., Pirie, A., Riggan, M. J., Chornokur, G., et al. (2017) · Nature Genetics · doi:10.1038/ng.3826 · Cited by 502
The Origin of Ovarian Cancer Species and Precancerous Landscape
Shih, I.-M., Wang, Y., & Wang, T.-L. (2021) · The American Journal of Pathology · doi:10.1016/j.ajpath.2020.09.006 · Cited by 255
Self-citationChemotherapy resistance in epithelial ovarian cancer: Mechanisms and emerging treatments
Marchetti, C., De Felice, F., Romito, A., Iacobelli, V., Sassu, C. M., Corrado, G., Ricci, C., Scambia, G., & Fagotti, A. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.08.011 · Cited by 139
Metadata
- Authors
- Vang, R., Shih, I., & Kurman, R. J.
- Venue
- Histopathology
- Publisher
- Wiley
- Published
- 2012-12-13
- Volume
- 62
- Issue
- 1
- Pages
- 44-58
- ISSN
- 0309-0167 (ISSN-L)
- 1365-2559
- OpenAlex
- W2012975737
- Cited by
- 281
- References
- 57
- FWCI
- 24.85
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.